473
Views
13
CrossRef citations to date
0
Altmetric
Perspectives

Congress 60: An Addiction Recovery Community within the Islamic Republic of Iran

REFERENCES

  • Afkhami, A. A. (2009). From punishment to harm reduction: Resecularization of addiction in contemporary Iran. In A. Gheissari (Ed.), Contemporary Iran: Economy, society, politics (pp. 194–210). Oxford, England: Oxford University Press.
  • Ahmadi, J. (2002). Buprenorphine maintenance treatment of heroin dependence: The first experience from Iran. Journal of Substance Abuse Treatment, 22(3), 157–159. doi:10.1016/S0740-5472(02)00222-2
  • Ahmadi, J., Arabi, H., & Mansouri, Y. (2003). Prevalence of substance use among offspring of opioid addicts. Addictive Behaviors, 28, 591–595. doi:10.1016/S0306-4603(01)00260-X
  • Ahmadi, J., Babaee-Beigi, M., Alishahi, M., Maany, I., & Hidari, T. (2004). Twelve-month maintenance treatment of opium-dependent patients. Journal of Substance Abuse Treatment, 26, 6–64. doi:10.1016/S0740-5472(03)00141-7
  • Ahmadi, J., & Motamed, F. (2003). Treatment success rate among Iranian opioid dependents. Substance Use & Misuse, 38(1), 151–163. doi:10.1081/JA-120016571
  • Ahmadi, J., Pridmore, S., Alimi, A., Cheraghi, A., Arad, A., Parsaeyan, H., … Kianpour, M. (2007). Epidemiology of opium use in the general population. American Journal of Drug and Alcohol Abuse, 33(3), 483–491. doi:10.1080/00952990701301293
  • Ali, R., Jittiwutikarn, J., Hall, J., White, J., Christie, P., Bochner, F., … Gray, J. (2000). Tincture of opium and the use of heroin in Adelaide's Vietnamese community (DASC Monograph No. 7 Research Series). Adelaide, Australia: Drug and Alcohol Services Council.
  • Aliverdinia, A., & Pridemore, W. A. (2008). An overview of the illicit narcotics problem in the Islamic Republic of Iran. European Journal of Crime, Criminal Law and Criminal Justice, 16, 155–170. doi:10.1163/157181708X308434
  • Ataee, M., Jouybari, A., Alavijeh, M. M., Aghaei, A., Mahboubi, M., & Motlagh, F. Z. (2014). Factors related with intention to methadone maintenance treatment among Iranian men addicts. Life Science Journal, 11(4s), 228–231.
  • Auriacombe, M., Grabot, D., Daulouède, J. P., Vergnolle, J. P., O'Brien, C., & Tignol, J. (1993). Alternatives to methadone maintenance: Laudanum, buprenorphine. In L. Harris (Ed.), Problems of drug dependence, 1992: Proceedings of the 54th Annual Scientific Meeting the College on Problems of Drug Dependence, Inc. research monograph 132 (p. 308). Rockville, MD: U.S. Department of Health and Human Services.
  • Auriacombe, M., Grabot, D., Daulouède, J.-P., Vergnolle, J.-P., O'Brien, C., & Tignol, J. (1994). A naturalistic follow-up study of French-speaking opiate-maintained heroin-addicted patients: Effects on biopsychosocial status. Journal of Substance Abuse Treatment, 11(6), 565–568. doi:10.1016/0740-5472(94)90008-6
  • Calabrese, J. (2007). Iran's war on drugs: Holding the line? The Middle East Institute, Policy Brief, 3, 1–18. Retrieved from http://www.mideasti.org/content/irnas-war-drugs-holding-line?page=16
  • Chandrasena, R. (1980). Management of opium dependence in a general hospital psychiatry unit. British Journal of Addiction, 75(2), 163–167. doi:10.1111/j.1360-0443.1980.tb02441.x
  • Cloud, W., & Granfield, R. (2008). Conceptualizing recovery capital: Expansion of a theoretical construct. Substance Use and Misuse, 43(12/13), 1971–1986. doi:10.1080/10826080802289762
  • Dahmardehei, M., & Rafaiee, R. (2012). Opium syrup distribution, limitation and challenges. Zahedan Journal of Research in Medical Sciences, 16(6), 48.
  • Day, C., Nassirimanesh, B., Shakeshaft, A., & Dolan, K. (2006). Patterns of drug use among a sample of drug users and injecting drug users attending a general practice in Iran. Harm Reduction Journal, 3, 2. doi:10.1186/1477-7517-3-2
  • De Leon, G., Staines, G. L., Perlis, T. E., Sacks, S., McKendrick, K., Hilton, R., & Brady, R. (1995). Therapeutic community methods in methadone maintenance (Passages): An open clinical trial. Drug and Alcohol Dependence, 37, 45–57. doi:10.1016/0376-8716(94)01057-R
  • Dezhakam, H. (2011a). Crossing the zone 60 degrees below zero. Tehran, Iran: Congress 60.
  • Dezhakam, H. (2011b). Love: Fourteen valleys for recovery. Tehran, Iran: Congress 60.
  • Dolan, K., Salimi, S., Nassirimanesh, B., Mohsenifar, S., Allsop, D., & Mokri, A. (2011). Characteristics of Iranian women seeking drug treatment. Journal of Women's Health, 20(11), 1687–1691. doi:10.1089/jwh.2010.2694
  • Dolan, K., Salimi, S., Nassirimanesh, B., Mohsenifar, S., & Mokri, A. (2011). The establishment of a methadone treatment clinic for women in Tehran, Iran. Journal of Public Health Policy, 32, 219–230. doi:10.1057/jphp.2011.10
  • Dole, V. P., & Nyswander, M. E. (1967). Heroin addiction—a metabolic disease. Archives of Internal Medicine, 120, 19–24. doi:10.1001/archinte.1967.00300010021004
  • Dole, V. P., Nyswander, M. E., & Kreek, M. J. (1966). Narcotic blockade. Archives of Internal Medicine, 118, 304–309. doi:10.1001/archinte.1966.00290160004002
  • Eskandarieh, S., Nikfarjam, A., Tarjoman, T., Nasehi, A., Jafari, F., & Saberi-Zafarghandi, M.-B. (2013). Descriptive aspects of injection drug users in Iran's national harm reduction program by methadone maintenance treatment. Iran Journal of Public Health, 42(6), 588–593.
  • Esmaeli, H.-R., Ziaddinni, H., Nikravesh, M.-R., Baneshi, M.-R., & Nakhaee, N. (2014). Outcome evaluation of the opioid agonist maintenance treatment in Iran. Drug and Alcohol Review, 33(2), 186–193. doi:10.1111/dar.12112
  • Evans, A. C., White, W. L., & Lamb, R. (2013). The role of harm reduction in recovery-oriented systems of care: The Philadelphia experience. Philadelphia, PA: Department of Behavioral Health and Intellectual disAbility Services. Retrieved from http://www.williamwhitepapers.com/pr/Recovery%20and%20Harm%20Reduction%20In%20Philadelphia.pdf (Accessed June 15, 2015).
  • Farnam, R. (2005). Substance abuse in Iran: A brief overview. Retrieved from http://uclaisap.org/slides/dssat2005/Farnam.pdf
  • Farnia, M., Ebrahimi, E., Shams, A., & Zamani, S. (2010). Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran. International Journal of Drug Policy, 21, 422–424. doi:10.1016/j.drugpo.2010.03.008
  • Fathi, N. (2008, June 27). Iran fights scourge of addiction in plain view, stressing treatment. New York Times. Retrieved from http://www.nytimes.com/2008/06/27/world/middleeast/27addiction.html?pagewanted=all&_r=0
  • Figg-Franzoi, L. (2011). Maslahat, the state and the people: Opium use in the Islamic Republic of Iran. Crime, Law and Social Change, 56(4), 421–438. doi:10.1007/s10611-011-9326-1
  • Ghanizadeh, A., Ashkani, H., & Maany, I. (2000). Comorbidity of psychiatric disorders in Iranian treatment-seeking opioid addicts. Iranian Journal of Medical Sciences, 25(1&2), 25–30.
  • Gruber, V. A., Delucchi, K. L., Kielestein, A., & Batiki, S. L. (2008). A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug and Alcohol Dependence, 94, 199–206. doi:10.1016/j.drugalcdep.2007.11.021
  • Iranian National Center for Addiction Studies. (2007). Iranian National Center for Addiction Studies. Iranian Journal of Psychiatry and Behavioral Sciences, 1(1), 41–42.
  • Jittiwutikarn, J., Ali, R., White, J. M., Bochner, F., Somogyi, A. A., & Foster, D. J. R. (2004). Comparison of oral tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre. British Journal of Clinical Pharmacology, 58(5), 536–541. doi:10.1111/j.1365-2125.2004.02209.x
  • Kellogg, S. H. (2003). On “gradualism” and the building of the harm reduction—abstinence continuum. Journal of Substance Abuse Treatment, 25, 241–247. doi:10.1016/S0740-5472(03)00068-0
  • Kobra, L., Mohammad, B. N., & Alireza, S. S. (2012). Quality of life in patients on methadone maintenance treatment: A three-month assessment. Journal of the Pakistan Medical Association, 62, 1003–1007.
  • Koob, G. F. (2009). Dynamics of neuronal circuits in addiction: Reward, antireward, and emotional memory. Pharmacopsychiatry, 42, S32–S41. doi:10.1055/s-0029-1216356
  • Kreek, M. J. (2000). Methadone-related opioid agonist pharmacotherapy for heroin addiction: History, recent molecular and neurochemical research and future in mainstream medicine. Annals of the New York Academy of Sciences, 909, 186–216. doi:10.1111/j.1749-6632.2000.tb06683.x
  • Kreek, M. J. (2010). Overview and historical perspective of four papers presented on research related to the endogenous opioid system. Drug and Alcohol Dependence, 108, 195–199. doi:10.1016/j.drugalcdep.2010.03.003
  • Lavitt, J. (2014). The crescent and the needle: The remarkable rise of NA in Iran. Retrieved from http://www.thefix.com/content/Iran-Narcotics-Anonymous-phonemoneon-Lavitt2099?page=all
  • Maarefvand, M., Ghiasvand, H. R., & Ekhtiari, H. (2013). Drug craving terminology among opiate dependents: A mixed method study. Iranian Journal of Psychiatry, 8(2), 97–103.
  • Maltais, K. (2011). 20,000 Iranian addicts gather to celebrate recovery. Retrieved from http://www.thefix.com/content/200000-iranian-addicts-gather-celebrate-recovery
  • Marlatt, G. A., Blume, A. W., & Parks, G. A. (2001). Integrating harm reduction therapy and traditional substance abuse treatment. Journal of Psychoactive Drugs, 33(1), 13–21. doi:10.1080/02791072.2001.10400463
  • Matthee, R. (2005). The pursuit of pleasure: Drugs and stimulants in Iranian history, 1500–1900. Princeton, NJ: Princeton University Press.
  • McLellan, A. T., Hagan, T. A., Levine, M., Gould, F., Meyers, K., Bencivengo, M., & Durell, J. (1998). Supplemental social services improve outcomes in public addiction treatment. Addiction, 93(10), 1489–1499. doi:10.1046/j.1360-0443.1998.931014895.x
  • McLellan, A. T., Woody, G. E., Luborsky, L., & Goehl, L. (1988). Is the counselor an ‘active ingredient’ in substance abuse rehabilitation? An examination of treatment success among four counselors. Journal of Nervous and Mental Disease, 176, 423–430.
  • Mehrjerdi, Z. A. (2013). Crystal in Iran: Methamphetamine or heroin kerack. DARU Journal of Pharmaceutical Sciences, 21, 22. doi:10.1186/2008-2231-21-22
  • Mehrjerdi, Z. A., & Zarghami, M. (2013). Maintenance therapy with opium tincture for injecting drug users: Implications for prevention from viral infections. Hepatitis Monthly, 13(4), E8334. doi:10.5812/hepatmon.8334
  • Mirlashari, J., Demirkol, A., Salsali, M., Rafiey, H., & Jahahbani, J. (2012). Early childhood experiences, parenting and the process of drug dependency among young people in Tehran, Iran. Drug and Alcohol Review, 31(4), 461–468. doi:10.1111/j.1465.3362.2011.00384.x
  • Moeni, M., Razzaghi, O. M., Mahmood, M., & Pashaeie, T. (2014). Analysis of retention among a sample of opioid dependents participating in the Methadone Maintenance Treatment Program in Iran. Journal of the School of Public Health and Institute of Public Health Research, 11(3), 55–64.
  • Mohammad, K. A., Hassan, S., & Dariush, B. (2011). Crack in Iran: Is it really cocaine? Journal of Addiction Research & Therapy, 2, 107. doi:10.4172/2155-6105.1000107
  • Mohammad, K. (2007, March 25). Iran's in a fix. The Daily Mail (London).
  • Mohammadpoorasl, A., Fakhari, A., Akbari, H., Karimi, F., Bostanabad, M. A., Rostami, F., & Hajizadeh, M. (2012). Addiction relapse and its predictors: A prospective study. Journal of Addiction Research & Therapy, 3, 122. doi:10.4172/2155-6105.1000122
  • Mokri, A. (2002). Brief overview of the status of drug abuse in Iran. Archives of Iranian Medicine, 5(3), 184–190.
  • Movaghar, A. R., Langroodi, Z. M., Ahmadi, S. D., & Esmaeili, M. A. (2011). A qualitative study of specific needs of women for treatment of addiction. Iranian Journal of Psychiatry and Clinical Psychology, 17(2), 116–125.
  • Namdarpour, F., & Iravani, M. R. (2013). The survey study effect of feedback on the willingness of Holland's theory of interest the spouses of addicts, the quality of life. Journal of Social Issues & Humanities, 1(4), 45–48.
  • Narimani, M., & Sadeghieh, S. A. (2008). A study of the rate and causes of addiction relapse among volunteer addicts seeking help at the Center for the Prevention of Addiction affiliated to the Welfare Organization, Ardabil Province, Iran. Research Journal of Biological Sciences, 3(2), 258–264.
  • Nataparan, C. (2000). Methadone maintenance and harm reduction in Northern Thailand. Retrieved from http://www.drugtext.org/Opiates-heroin-methadone/methadone-maintenance-and-harm-reduction-in-northern-thailand.html
  • Rahimi-Movaghar, A., Hefazi, M., Davoli, M., Amato, L., Amin-Esmaeili, M., Sahimi-Izadian, E., & Yousefi-Nooraie, R. (2009). Pharmacological therapies for management of opium withdrawal. Cochrane Database of Systematic Reviews, 1, Art. No. CD007522. doi:10.1002/14651858.CD007522
  • Rahimi-Movaghar, A., Khastoo, G., Razzaghi, E., Saberi-Zafarghandi, M. B., Noroozi, A. R., & Jar-Siah, R. (2011b). Compulsory methadone maintenance treatment of severe cases of drug addiction in a residential setting in Tehran, Iran (1): Process evaluation. Payesh Health Monitor, 10(4), 493–503.
  • Rahimi-Movaghar, R., Khastoo, G., Razzaghi, E., Saberi-Zafarghandi, M. B., Norrozi, A. R., & Jar-Siah, R. (2011a). Compulsory methadone maintenance treatment of severe cases of drug addiction in a residential setting in Tehran, Iran: Outcome evaluation in two and six-month follow-up. Payesh Health Monitor, 10(4), 505–514.
  • Rahimi-Movaghar, R., Mohammad, K., & Razzaghi, E. M. (2002). Trend of drug abuse situation in Iran: A three-decade review. Hakim Research Journal, 5(3), 171–181.
  • Rahimpour, R., Khankeh, H. R., Khoshknab, M. F., Farhoodian, A., & Farzi, F. (2012). The evaluation of marital adjustment of the addicts in Isfahan NA groups and their couples. Iranian Rehabilitation Journal, 10(15), 13–17.
  • Razzaghi, E. M., Rahnimi, A., Hosseni, M., Madani, S., & Chaterjee, A. (1999). Rapid Situation Assessment (RSA) of drug abuse in Iran (1998–1999). Tehran, Iran: Ministry of Health, I.R. of Iran and United Nations International Drug Control Program State Welfare Organizations, Prevention Department.
  • Richards, I., & Henry-Edwards, S. (2002). Proceedings Workshop for Pharmacotherapies to Manage Opioid Dependence in Asia, Beijing, August 5–7. DASC Monograph No. 12 Research Series. Adelaide, Australia: Drug and Alcohol Services Council.
  • Roshani, B., Jalali, A., Bidhendi, S., Ezzati, E., & Mahboubi, M. (2014). Study the causes of relapse among Iranian drugs users in Kermanshah. Life Science Journal, 11(1s), 66–71.
  • Rouhani, S., Kheirkhak, F., Salarieh, I., & Abedi, S. (2012). Quality of life, its early change and retention in MMT programs in Iran: Evidence for policymakers and service providers. Life Science Journal, 9(3), 2633–2638.
  • Sadir, N., Shojaei, M., Moadab, K., Ababasi, R., Bahrampour, A., & Nakjhee, N. (2013). Outcome evaluation of therapeutic community model in Iran. International Journal of Health Policy Management, 1(2), 131–135.
  • Sayyah, S. (2006, June 8). Narcotics Anonymous in Iran. Payvand News of Iran. Retrieved from http://www.pavand.com.news/o6/jun/1070.html
  • Schwartz, R. P., Kelly, S. M., O'Grady, K. E., Gandhi, D., & Jaffe, J. H. (2011). Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings. Addiction, 107, 943–952. doi:10.1111/j.1360-0443.2011.03700.x
  • Shahrbabaki, M. E., Ziaaddini, H., Doost, A. A. H., Ghasemi, M., Shahrbabaki, P. E., Nouri, R. A., & Sharrbabaki, N. S. (2011). Methadone treatment in Iranian opiate addicts: A preliminary report. Addiction & Health, 3(1/2), 53–60.
  • Shariatirad, S., & Maarefvand, M. (2013). Sanctions against Iran and the impact on drug use and addiction treatment. International Journal of Drug Policy, 24(6), 636–637. doi:10.1016/j.drugpo.2013.04.003
  • Sharifi, H., Kharaghani, R., Sigari, S., Emami, H., Sadr, M., & Masjedi, M. R. (2012). Common methods to treat addiction in treatment-rehabilitation centers in Tehran. Iranian Journal of Public Health, 41(4), 63–68.
  • Shekarchizadeh, H., Ekhtiari, H., Khami, M. R., & Virtanen, J. I. (2012). Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance in Iran. Harm Reduction Journal, 9, 18. doi:10.1186/1477-7517-9-18
  • Somogyi, A. A., Larsen, M., Abadi, R. M., Jittiwutikarn, J., Ali, R., & White, J. M. (2008). Flexible dosing of tincture of opium in the management of opioid withdrawal: Pharmacokinetics and pharmacodynamics. British Journal of Pharmacodynamics, 66(5), 640–647. doi:10.1111/j.1365-2125.2008.03277.x
  • Sorensen, J. L., Andrews, S., Delucchi, K. L., Greenberg, B., Guydish, J., Masson, C. L., & Shopshire, M. (2009). Methadone patients in the therapeutic community: A test of equivalency. Drug and Alcohol Dependence, 100(1/2), 100–106. doi:10.1016/j.drugalcdep.2008.09.009
  • Tabatabaei-Jafari, H., Ekhtiari, H., Ganjgahi, H., Hassani-Abharian, P., Oghabian, M. A., Moradi, A, … Zarei, M. (2014), Patterns of brain activation during craving in heroin dependents successfully treated by methadone maintenance and abstinence-based treatments. Journal of Addiction Medicine, 8(2), 123–129. doi:10.1097/ADM.0000000000000022
  • Tanner, I. (2013, August 23). The lion chases away the dragon: Iran's drug treatment programs are among the world's most progressive. The Majalla: The Leading Arab Magazine. Retrieved from http://www.majalla.com/eng/2013/08/article55244942.
  • Tavakoli, M. (2013). The influence of detoxification on the quality of life in substance addicts lives with 40–65 years of age referring to the charity Congress60. Iranian Journal of Ageing, 6(23), 3. Retrieved from http://www.yektawebsite.ir/∼salmand/search.php?slc_lang=en&sid=1&auth=Tavakoli
  • Tavakoli, M., Sahaf, R., Ghaffari, S., Farhoudian, A., & Hayatbakhsh, R. (2012). Cost benefit analysis of detoxification in addicts over 40 in human recovery population (Congress 60). Quarterly Journal of Rehabilitation, 12(5), 52–57.
  • Trigo, J. M., Martin-Garcia, E., Berrendero, F., Robledo, P., & Maldonado, R. (2010). The endogenous opioid system: A common substrate in drug addiction. Drug and Alcohol Dependence, 108, 183–194. doi:10.1016/j.drugalcdep.2009.10.011
  • White, W. L. (1996). Pathways from the culture of addiction to the culture of recovery. Center City, MN: Hazelden.
  • White, W. L. (1998). Slaying the dragon: The history of addiction treatment and recovery in America. Bloomington, IL: Chestnut Health Systems.
  • White, W. L. (2011). An addiction recovery community in the Islamic Republic of Iran: An interview with Mr. Hossein Dezhakam, founder, Congress60. Retrieved from http://www.williamwhitepapers.com/pr/2011%20Iran%20Mr%20Hossein%20Dezhakam.pdf
  • White, W. L. (2012a). Medication-assisted recovery from opioid addiction: Historical and contemporary perspectives Journal of Addictive Diseases, 31(3), 199–206. doi:10.1080/10550887.2012.694597
  • White, W. L. (2012b). Smoking cessation within a recovery community: An interview with Hossein Dezhakam, Congress60, Iran. Retrieved from http://www.williamwhitepapers.com/pr/2012%20Smoking%20Cessation%20in%20Congress60%20Hossein%20Dezhakam%2C%20Iran.pdf
  • White, W. L., Campbell, M. D., Spencer, R. A., Hoffman, H. A., Crissman, B., & DuPont, R. L. (2014). Participation in Narcotics Anonymous and Alcoholics Anonymous and abstinence outcomes of 322 methadone maintenance patients. Journal of Groups in Addiction and Recovery, 9(1), 14–30. doi:10.1080/1556035X.2014.888883
  • White, W. L., & Torres, L. (2010). Recovery-oriented methadone maintenance. Chicago, IL: Philadelphia Department of Behavioral Health and Intellectual disAbility Services and Northeast Addiction Technology Transfer Center, Great Lakes Addiction Technology Transfer Center.
  • Zamani, S., Kihara, M., Gouya, M., Vazirian, M., Nassirimanesh, B., Ono-Kihara, M., … Icikawa, S. (2006). High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. Journal of Acquired Immune Deficiency Syndromes, 42(3), 342–346. doi:10.1097/01.qai.0000219785.81163.67
  • Zarrindast, M.-R., Sahraei, H., & Dejakam, H. (2010). New dimension in drug addiction therapy. Basic and Clinical Neuroscience, 1(4), 67–68.
  • Ziaaddini, H., & Ziaaddini, R. (2005). The household survey of drug abuse in Kerman, Iran. Journal of Applied Sciences, 5(2), 380–382.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.